Cardiac Surgery

Home / Specialties / Cardiovascolare / Cardiochirurgia

Gada Italia supports cardiac surgery professionals with a wide range of cutting-edge solutions designed to assist in complex procedures and improve clinical outcomes.

Gada Italia supports cardiac surgery professionals with an extensive range of advanced solutions designed to assist complex procedures and improve clinical outcomes. From ventricular support to extracorporeal circulation, ECMO solutions, eCPR resuscitation systems, and vascular repair and closure devices, we provide cutting-edge technologies that ensure maximum safety, precision, and reliability.
Our commitment is to provide effective tools to optimize clinical procedures, reduce recovery times, and enhance patients’ quality of life, collaborating with healthcare facilities to elevate standards of care in cardiovascular surgery.

1

Wide coverage of cardiothoracic fields

2

Cutting-edge technologies

3

Support for clinical outcomes

4

Reduced recovery times

5

Optimization of clinical procedures

Discover in detail our solutions for every aspect of cardiac surgery.

Our ventricular assist systems provide temporary cardiac support during or after complex cardiac procedures in hemodynamically unstable patients or those in cardiogenic shock. These systems help stabilize the patient’s condition and improve cardiac function.

Among the available solutions, the Impella CP® withSmartAssist® andImpella 5.5® with SmartAssist® systems offer advanced left ventricular support, playing a crucial role in patients with acute heart failure or cardiogenic shock.

  • Impella CP® with SmartAssist®: A percutaneous device providing up to 4.3 L/min of support, ideal for hemodynamically unstable patients or those undergoing high-risk PCI. SmartAssist® technology enables continuous monitoring and optimal positioning.
    • Minimally invasive access
    • Immediate hemodynamic stability
  • Impella 5.5® with SmartAssist®: Provides up to 5.5 L/min of support with subclavian insertion, allowing greater mobility and extended use. Suitable for persistent cardiogenic shock or as a bridge to definitive solutions.
    • Higher flow rate.
    • Improved mobility and comfort.
Our extracorporeal circulation solutions include high-performance oxygenators and oxygenation kits, essential for temporarily replacing cardiac and pulmonary functions during cardiac surgery. Thanks to their advanced technology, these systems help maintain patients’ vital balance in critical situations, ensuring safety and efficiency during complex procedures. Among our solutions for extracorporeal circulation, Terumo Capiox FX Advance oxygenators, customized circuits and kits, and CDI OneView monitoring offer advanced performance for complex cardiac surgeries, contributing to the safe and efficient execution of procedures in the operating room. Capiox FX Advance: High-performance oxygenators designed for optimal cardiopulmonary bypass (CPB) management, ensuring efficient gas exchange while maintaining excellent biocompatibility through a dedicated coating applied to blood-contact surfaces.
  • Customized circuits and kits: tailor-made devices designed to optimize workflows and preparation times.
  • CDI OneView: real-time monitoring of blood gas parameters for more precise perfusion management.

To improve survival and neurological function in patients suffering from refractory cardiac arrest, we offer a specialized range of products designed for eCPR (Extracorporeal CardioPulmonary Resuscitation). The primary goal of this approach is to support the patient’s circulation and subsequently facilitate the return of spontaneous circulation.

Another key objective is to minimize ischemia-reperfusion injury, a highly damaging phenomenon that occurs during extracorporeal reperfusion following refractory cardiac arrest.

In this context, the CARL® system by Resuscitec represents a novel solution for eCPR, optimizing the conditions of reperfusion and the quality of the reperfused blood in patients affected by refractory cardiac arrest. Through advanced control of hemodynamic and metabolic parameters, CARL® aims to reduce ischemia-reperfusion damage, improve neurological outcomes, and increase the chances of patient recovery.

We offer patches made from specialized materials crafted to maximize compatibility and durability, essential for their delicate application in pediatric procedures. These solutions are designed to ensure safe and precise interventions, significantly improving patients’ quality of life.
Among our solutions:

Vascular prostheses

Included in our product portfolio is also GORE®PROPATEN® Vascular Graft configured for Pediatric Shunt: indicated for staged palliative repair of cyanotic congenital heart disease, includes CBAS® Heparin Surface that provides long-term thromboresistance.

Our range of ECMO solutions includes high-quality equipment and oxygenator kits designed to support cardiac function in critical conditions. ECMO, or extracorporeal membrane oxygenation, is vital for patients requiring circulatory and blood oxygenation assistance during severe respiratory and/or cardiac failure.

Among our ECMO solutions, Hemovent MobyBox® is a portable and compact system highly suited for cardiac support in critical situations. Given its features, MOBYBOX® combines versatility and ease of use, making it ideal for emergency and intensive care applications.

Our advanced extracorporeal hemoadsorption solutions are designed to effectively support the management of critically ill patients suffering from severe systemic inflammatory conditions.

In this context, Efferon® LPS represents the new generation of hemoadsorption devices for the extracorporeal treatment of sepsis and septic shock. It is a groundbreaking therapeutic solution that selectively removes endotoxins and adsorbs cytokines, promoting the restoration of immune-inflammatory balance and hemodynamic stabilization of the patient.

Our ventricular assist systems provide temporary cardiac support during or after complex cardiac procedures in hemodynamically unstable patients or those in cardiogenic shock. These systems help stabilize the patient’s condition and improve cardiac function.

Among the available solutions, the Impella CP® withSmartAssist® andImpella 5.5® with SmartAssist® systems offer advanced left ventricular support, playing a crucial role in patients with acute heart failure or cardiogenic shock.

  • Impella CP® with SmartAssist®: A percutaneous device providing up to 4.3 L/min of support, ideal for hemodynamically unstable patients or those undergoing high-risk PCI. SmartAssist® technology enables continuous monitoring and optimal positioning.
    • Minimally invasive access
    • Immediate hemodynamic stability
  • Impella 5.5® with SmartAssist®: Provides up to 5.5 L/min of support with subclavian insertion, allowing greater mobility and extended use. Suitable for persistent cardiogenic shock or as a bridge to definitive solutions.
    • Higher flow rate.
    • Improved mobility and comfort.
Our extracorporeal circulation solutions include high-performance oxygenators and oxygenation kits, essential for temporarily replacing cardiac and pulmonary functions during cardiac surgery. Thanks to their advanced technology, these systems help maintain patients’ vital balance in critical situations, ensuring safety and efficiency during complex procedures. Among our solutions for extracorporeal circulation, Terumo Capiox FX Advance oxygenators, customized circuits and kits, and CDI OneView monitoring offer advanced performance for complex cardiac surgeries, contributing to the safe and efficient execution of procedures in the operating room. Capiox FX Advance: High-performance oxygenators designed for optimal cardiopulmonary bypass (CPB) management, ensuring efficient gas exchange while maintaining excellent biocompatibility through a dedicated coating applied to blood-contact surfaces.
  • Customized circuits and kits: tailor-made devices designed to optimize workflows and preparation times.
  • CDI OneView: real-time monitoring of blood gas parameters for more precise perfusion management.

To improve survival and neurological function in patients suffering from refractory cardiac arrest, we offer a specialized range of products designed for eCPR (Extracorporeal CardioPulmonary Resuscitation). The primary goal of this approach is to support the patient’s circulation and subsequently facilitate the return of spontaneous circulation.

Another key objective is to minimize ischemia-reperfusion injury, a highly damaging phenomenon that occurs during extracorporeal reperfusion following refractory cardiac arrest.

In this context, the CARL® system by Resuscitec represents a novel solution for eCPR, optimizing the conditions of reperfusion and the quality of the reperfused blood in patients affected by refractory cardiac arrest. Through advanced control of hemodynamic and metabolic parameters, CARL® aims to reduce ischemia-reperfusion damage, improve neurological outcomes, and increase the chances of patient recovery.

We offer patches made from specialized materials crafted to maximize compatibility and durability, essential for their delicate application in pediatric procedures. These solutions are designed to ensure safe and precise interventions, significantly improving patients’ quality of life.
Among our solutions:

Vascular prostheses

Included in our product portfolio is also GORE®PROPATEN® Vascular Graft configured for Pediatric Shunt: indicated for staged palliative repair of cyanotic congenital heart disease, includes CBAS® Heparin Surface that provides long-term thromboresistance.

Our range of ECMO solutions includes high-quality equipment and oxygenator kits designed to support cardiac function in critical conditions. ECMO, or extracorporeal membrane oxygenation, is vital for patients requiring circulatory and blood oxygenation assistance during severe respiratory and/or cardiac failure.

Among our ECMO solutions, Hemovent MobyBox® is a portable and compact system highly suited for cardiac support in critical situations. Given its features, MOBYBOX® combines versatility and ease of use, making it ideal for emergency and intensive care applications.

Our advanced extracorporeal hemoadsorption solutions are designed to effectively support the management of critically ill patients suffering from severe systemic inflammatory conditions.

In this context, Efferon® LPS represents the new generation of hemoadsorption devices for the extracorporeal treatment of sepsis and septic shock. It is a groundbreaking therapeutic solution that selectively removes endotoxins and adsorbs cytokines, promoting the restoration of immune-inflammatory balance and hemodynamic stabilization of the patient.